Research ArticleArticle
Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial
Emily W. Hung, Maureen D. Mayes, Roozbeh Sharif, Shervin Assassi, Victor I. Machicao, Chitra Hosing, E. William St. Clair, Daniel E. Furst, Dinesh Khanna, Stephen Forman, Shin Mineishi, Kristine Phillips, James R. Seibold, Christopher Bredeson, Mary Ellen Csuka, Richard A. Nash, Mark H. Wener, Robert Simms, Karen Ballen, Sharon LeClercq, Jan Storek, Ellen Goldmuntz, Beverly Welch, Lynette Keyes-Elstein, Sharon Castina, Leslie J. Crofford, Peter McSweeney and Keith M. Sullivan
The Journal of Rheumatology February 2013, jrheum.121087; DOI: https://doi.org/10.3899/jrheum.121087
Emily W. Hung
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Maureen D. Mayes
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Roozbeh Sharif
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Shervin Assassi
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Victor I. Machicao
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Chitra Hosing
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
E. William St. Clair
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Daniel E. Furst
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Dinesh Khanna
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Stephen Forman
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Shin Mineishi
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Kristine Phillips
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
James R. Seibold
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Christopher Bredeson
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Mary Ellen Csuka
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Richard A. Nash
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Mark H. Wener
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Robert Simms
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Karen Ballen
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Sharon LeClercq
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Jan Storek
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Ellen Goldmuntz
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Beverly Welch
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Lynette Keyes-Elstein
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Sharon Castina
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Leslie J. Crofford
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Peter McSweeney
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Keith M. Sullivan
From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA. Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA). E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St. Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky. Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA. E-mail: Maureen.d.mayes@uth.tmc.edu. Accepted for publication December 11, 2012.
Article Information
jrheum.121087
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online February 15, 2013.
Article Versions
- You are currently viewing a Latest version of this article (February 15, 2013 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2013 The Journal of Rheumatology
Author Information
- Emily W. Hung,
- Maureen D. Mayes,
- Roozbeh Sharif,
- Shervin Assassi,
- Victor I. Machicao,
- Chitra Hosing,
- E. William St. Clair,
- Daniel E. Furst,
- Dinesh Khanna,
- Stephen Forman,
- Shin Mineishi,
- Kristine Phillips,
- James R. Seibold,
- Christopher Bredeson,
- Mary Ellen Csuka,
- Richard A. Nash,
- Mark H. Wener,
- Robert Simms,
- Karen Ballen,
- Sharon LeClercq,
- Jan Storek,
- Ellen Goldmuntz,
- Beverly Welch,
- Lynette Keyes-Elstein,
- Sharon Castina,
- Leslie J. Crofford,
- Peter McSweeney and
- Keith M. Sullivan
- From Rheumatology Associates of Houston, a Division of Northwest Diagnostic Clinic, Houston, Texas; University of Texas Health Science Center at Houston, Houston, Texas; University of Texas Medical Branch, Galveston, Texas; MD Anderson Cancer Center, Houston, Texas; Duke University, Durham, North Carolina; University of California at Los Angeles, Los Angeles, California; University of Michigan, Ann Arbor, Michigan; City of Hope National Medical Center, Duarte, California; Scleroderma Research Consultants LLC, Avon, Connecticut, USA; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Medical College of Wisconsin, Milwaukee, Wisconsin; Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program, Denver, Colorado; University of Washington, Seattle, Washington; Boston University School of Medicine, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Calgary, Calgary, Alberta, Canada; NIH/NIAID, Bethesda, Maryland; Rho, Chapel Hill, North Carolina; and the University of Kentucky, Lexington, Kentucky, USA.
Supported by awards A1-05419 and HHSN272201100025C from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA).
E.W. Hung, MD, Rheumatology Associates of Houston; M.D. Mayes, MD, MPH; S. Assassi, MD, MS; V.I. Machicao, MD, University of Texas Health Science Center at Houston; R. Sharif, MD, University of Texas Medical Branch; C. Hosing, MD, MD Anderson Cancer Center; E.W. St.
Clair, MD; K.M. Sullivan, MD, Duke University; D.E. Furst, MD, University of California at Los Angeles; D. Khanna, MD, MS; S. Mineishi, MD; K. Phillips, MD, PhD, University of Michigan; S. Forman, MD, City of Hope National Medical Center; J.R. Seibold, MD, Scleroderma Research Consultants, LLC; C. Bredeson, MD, Ottawa Hospital Research Institute; M.E. Csuka, MD, Medical College of Wisconsin; R.A. Nash, MD; P. McSweeney, MD, Colorado Blood Cancer Institute, Rocky Mountain Blood and Marrow Transplant Program; M.H. Wener, MD, University of Washington; R. Simms, MD, Boston University School of Medicine; K. Ballen, MD, Massachusetts General Hospital; S. LeClercq, MD; J. Storek, MD, PhD, University of Calgary; E. Goldmuntz, MD, PhD; B. Welch, RN, MSN, NIH/NIAID; L. Keyes-Elstein, DrPH; S. Castina, RN, MSN, Rho; L.J. Crofford, MD, University of Kentucky.
Address correspondence to Dr. M.D. Mayes, University of Texas Health Science Center at Houston, Rheumatology, 6431 Fannin Street, Medical School Building 5.270, Houston, TX 77030, USA.
E-mail: Maureen.d.mayes@uth.tmc.edu.
Accepted for publication December 11, 2012.
Article usage
Statistics from Altmetric.com
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial
Emily W. Hung, Maureen D. Mayes, Roozbeh Sharif, Shervin Assassi, Victor I. Machicao, Chitra Hosing, E. William St. Clair, Daniel E. Furst, Dinesh Khanna, Stephen Forman, Shin Mineishi, Kristine Phillips, James R. Seibold, Christopher Bredeson, Mary Ellen Csuka, Richard A. Nash, Mark H. Wener, Robert Simms, Karen Ballen, Sharon LeClercq, Jan Storek, Ellen Goldmuntz, Beverly Welch, Lynette Keyes-Elstein, Sharon Castina, Leslie J. Crofford, Peter McSweeney, Keith M. Sullivan
The Journal of Rheumatology Feb 2013, jrheum.121087; DOI: 10.3899/jrheum.121087
Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial
Emily W. Hung, Maureen D. Mayes, Roozbeh Sharif, Shervin Assassi, Victor I. Machicao, Chitra Hosing, E. William St. Clair, Daniel E. Furst, Dinesh Khanna, Stephen Forman, Shin Mineishi, Kristine Phillips, James R. Seibold, Christopher Bredeson, Mary Ellen Csuka, Richard A. Nash, Mark H. Wener, Robert Simms, Karen Ballen, Sharon LeClercq, Jan Storek, Ellen Goldmuntz, Beverly Welch, Lynette Keyes-Elstein, Sharon Castina, Leslie J. Crofford, Peter McSweeney, Keith M. Sullivan
The Journal of Rheumatology Feb 2013, jrheum.121087; DOI: 10.3899/jrheum.121087